Dose-related effects of n-demethyl-n-isopropyl-8,9-anhydroerythromycin a 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 37-40

  Choi, Myung Gyu ^a   Camilleri, Michael ^a   Burton, Duane D ^a   Johnson, Steven ^b   Edmonds, Anthony ^b  

^a MAYO CLINIC   (United States)

^b TAP Holdings Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8,9 ANHYDRO N ISOPROPYLNORERYTHROMYCIN A 6,9 HEMIACETAL; ERYTHROMYCIN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; MUSCLE FIBER CONTRACTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; STOMACH PARESIS; TREATMENT PLANNING;

ABDOMINAL PAIN; ADMINISTRATION, ORAL; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ERYTHROMYCIN; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; HEADACHE; HUMANS; MALE; MIDDLE AGED; NAUSEA;

EID: 0031968730     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Balagopal P, Ford GC, Ebenstein DB, Nadeau DA and Nair KS (1996) Mass spectrometric methods for determination of [13C]Leucine enrichment in human muscle protein. Analy Biochem 239:77-85.
2. Camilleri M, Brown ML and Malagelada J-R (1986) Impaired transit of chyme in chronic intestinal pseudo-obstruction: correction by cisapride. Gastroenterology 91:619-626.
3. Catnach SM, Ballinger AB, Stevens M, Fairclough PD, Trembath RC, Drury PL and Watkins PJ (1993) Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy. Gut 34:1123-1127.
4. Choi M-G, Camilleri M, Burton D, Zinsmeister AR, Forstrom LA and Nair KS (1997) 13c-octanoic acid breath test for gastric emptying of solids: Accuracy, reproduc ibility and comparison with scintigraphy. Gastroenterology 112:1155-1162.
5. 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 93:92-98.
6. Desautels SG, Hutson WR, Christian PE, Moore JG and Datz FL (1995) Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesis. Digest Dis Sci 40:141-146.
7. Duan LP, Braden B, Caspary WF and Lembcke B (1995) Influence of cisapride on gastric emptying of solids and liquids monitored by 13C breath tests. Digest Dis Sci 40:2200-2206.
8. Fiorucci S, Distrutti E, Gerli R and Morelli A (1994) Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term. Am J Gastroenterol 89:550-555.
9. Funabashi Y, Maeshiba Y, Inatomi N, Tanayama S, Harada S, Itoh Z and Omura S (1996) Bioactive metabolites of EM574 and EM523, erythromycin derivatives having strong gastrointestinal motor stimulating activity. J Antibiot 49:794-801
10. Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ and Vantrappen G (1993) Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104:1640-1647.
11. Holle GE, Steinbach E and Forth W (1992) Effects of erythromycin in the dog upper gastrointestinal tract. Am J Physiol 263:G52-9.
12. Inatomi N, Sato F, Marui S, Itoh Z and Omura S (1996) Vagus-dependent and vagus-independent mechanisms of action of the erythromycin derivative EM5T4 and motilin in dogs. Japanese Journal of Pharmacology 71:29-38.
13. Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, Muls E and Bouillon R (1990) Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med 322:1028-1031.
14. Kao CH, Wang SJ and Pang DY (1995) Effects of oral erythromycin on upper gastrointestinal motility in patients with non-insulin-dependent diabetes mellitus. Nuclear Med Commun 16:790-793.
15. Lazzaroni M, Sangaletti O and Bianchi Porro G (1987) Effect of cisapride on gastric emptying and ileal transit time of balanced liquid meal in healthy subjects, Digestion 37:110-113.
16. Lees GM and Percy WH (1981) Antibiotic-associated colitis: an in vitro investigation of the effects of antibiotics on intestinal motility. Br J Pharmacol 73:535-547.
17. Lin HC, Sanders SL, Gu YG and Doty JE (1994) Erythromycin accelerates solid emptying at the expense of gastric sieving. Digest Dis Sci 39:124-128.
18. Mathis C and Malbert CH (1995) Gastric but not duodenal motor effects of oral erythromycin are dose related. Neurogastroenterol Motil 7:47-54.
19. Minocha A and Galligan JJ (1991) Erythromycin inhibits contractions of nervemuscle preparations of the guinea pig small intestine. J Pharmacol Exp Ther 257:1248-1252.
20. Otterson MF and Sarna SK (1990) Gastrointestinal motor effects of erythromycin. Am J Physiol 259:G355-63.
21. Ohtawa M, Mizumoto A, Hayashi N, Yanagida K, Itoh Z and Omura S (1993) Mechanism of gastroprokinetic effect of EM523, an erythromycin derivative, in dogs. Gastroenterology 104:1320-1327.
22. Peeters TL (1993) Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105:1886-1899.
23. Ramirez B, Eaker EY, Drane WE, Hocking MP and Sninsky CA (1994) Erythromycin enhances gastric emptying in patients with gastroparesis after vagotomy and antrectomy. Digest Dis Sci 39:2295-2300.
24. Richards RD, Davenport K and McCallum RW (1993) The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 88:203-207.
25. Satoh M, Sakai T, Sano I, Fujikura K, Koyama H, Ohshima K, Itoh Z and Omura S (1994) EM574, an erythromycin derivative, is a potent motilin receptor agonist in human gastric antrum. J Pharmacol Exp Ther 271:574-579.
26. SAS Institute Inc. (1989) SAS/STAT Users Guide, Version 6, 4th ed., Vol. 2, PP 1135-1194, Cary, NC: SAS Institute.
27. Tanis AA, Baggen MG, Wiggers RH and Ouwendijk RJ (1993) Side-effects of oral erythromycin for treatment of diabetic gastroparesis. Lancet 342:1431.
28. Zara GP, Thompson HH, Pilot MA and Ritchie HD (1985) Effects of erythromycin on gastrointestinal tract motility. J Antimicrob Chemother 16(suppl A):175-179.